Free Newsletter
Register for our Free Newsletters
Advanced Composites
Amorphous Metal Structures
Analysis and Simulation
Asbestos and Substitutes
Associations, Research Organisations and Universities
Automation Equipment
Building Materials
Bulk Handling and Storage
CFCs and Substitutes
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
Medical Implants
Materials innovations designed to stimulate tissue regeneration recognised by industry award
Medical Implants : 15 January, 2010
A highly competitive award, sponsored by Amgen International, recognises BioCeramic Therapeutics' use of materials innovations to benefit patients with some of the most serious orthopaedic and dental conditions by stimulating and assisting in the body's natural tissue regeneration processes. The materials innovations also have potential future applications in soft tissue regeneration.
Funding round in BioCeramic Therapeutics headed by Imperial Innovations
Medical Implants : 10 January, 2010
Leading technology commercialisation and investment company Imperial Innovations (AIM: IVO, 'Imperial Innovations'), together with Longbow Capital LLP, has led a funding round for BioCeramic Therapeutics, with a first closing of
New chairman succeeds Sir Richard Sykes at BioCeramic Therapeutics
Medical Implants : 19 October, 2009
Dr Stephan Rietiker has been appointed chairman of the board of directors of the emerging leader in the field of novel biomaterials for healthcare, BioCeramic Therapeutics (BCT).
Elderly patients have a high risk of stroke within six months of a heart attack
Medical Implants : 14 April, 2006
Twenty percent of older patients who have suffered a heart attack have a one in 25 chance of being hospitalized for a stroke within six months of discharge from the hospital, according to research at Yale.
More patients would refuse treatment if they knew the outcome would mean greatly impaired quality of life
Medical Implants : 13 April, 2006
More patients would refuse life-sustaining treatment if they knew the outcome would be a life of severe functional or cognitive impairment, according to a study by a Yale researcher published Thursday in the New England Journal of Medicine.
Anti-fungal agent that curbed cocaine use in rodents has opposite effect in humans
Medical Implants : 11 April, 2006
Ketoconazole, an anti-fungal agent that helps curb cocaine use in laboratory rats, stimulates rather than reduces cocaine and heroin use in humans, according to a study by researchers at Yale School of Medicine.
Yale researchers report on brain activity believed related to sudden infant death syndrome
Medical Implants : 08 April, 2006
Neurons thought to play a key role in sudden infant death syndrome are located near some of the largest arteries in the brain, according to a study by a Yale School of Medicine research team published in this week's issue of the journal Nature Neuroscience.
Biodegradable polymers in medical applications
Medical Implants : 27 March, 2006
Rapra Technology, Europe's leading polymer research and test house, has secured 1.4 Million Euros of EU funding and assembled a consortium that will develop highly innovative supercritical fluid processing technology in order to make advanced multifunctional biodegradable polymer devices.
Going the extra mile for specialized heart attack care
Medical Implants : 13 March, 2006
Diverting ambulances with patients suffering a heart to a hospital providing emergency angioplasty rather than a closer hospital with no ability to provide this specialized care, may be feasible for the majority of Americans, researchers at Yale School of Medicine and the University of Michigan report in Circulation.
Researchers identify gene that protects against kidney stones
Medical Implants : 13 March, 2006
New Haven, Conn, Yale School of Medicine researchers report in Nature Genetics this week that they have identified a gene whose function protects the body against kidney stones.
Whiplash injury much more severe when head is turned
Medical Implants : 13 March, 2006
Persons whose heads are turned at the time of a rear impact collision risk a much more serious whiplash injury with potentially chronic symptoms, and a current Yale School of Medicine study explains why.
ADHD medication might also treat hyperactivity symptoms in autism
Medical Implants : 22 November, 2005
Methylphenidate, a medication used to treat attention-deficit hyperactivity disorder, may be effective in treating hyperactivity symptoms in children with autism and related pervasive developmental disorders, researchers report in the November Archives of General Psychiatry.
Study has implications for vaccine design and autoimmune diseases
Medical Implants : 18 November, 2005
A report in Nature November 17 by Yale School of Medicine researchers emphasizes which cells are important in mounting an antibody response to invading microbes.
Sleep apnea significantly increases risk for stroke and death
Medical Implants : 10 November, 2005
Sleep apnea, a condition where people stop breathing repeatedly while asleep, increases the risk of stroke and death, according to a study from Yale School of Medicine published November 10 in the New England Journal of Medicine.
Panel at Yale will examine issues of women and health care
Medical Implants : 02 November, 2005
The Women Faculty Forum at Yale and the Yale Office of WorkLife will present a free and public forum on November 16 focusing on women's healthcare from a variety of perspectives.
Study clarifies source of lymph node swelling in infections
Medical Implants : 25 October, 2005
Contrary to popular belief, lymph nodes swell due to recruitment of lymphocytes that are not specific for any given microbe, according to a report by Yale School of Medicine researchers in this week's Proceedings of the National Academy of Sciences.
Cool therapy reduces brain injury and death from oxygen loss in newborns
Medical Implants : 13 October, 2005
Infants born with oxygen loss who are given an innovative therapy that lowers their entire body temperature by four degrees within the first six hours of life, have a better chance of survival and lower incidence of brain injury, according to a report in today's issue of The New England Journal of Medicine.
Streamlining treatment of heart attack patients
Medical Implants : 29 September, 2005
In the first study of its kind, researchers at Yale School of Medicine show how hospitals can streamline procedures to reduce the time they take to treat heart attack patients.
Overlapping genetic factors in pathological gambling and major depression
Medical Implants : 22 September, 2005
The correlation between pathological gambling and major depression in middle-aged men appears to be heavily influenced by overlapping genetic factors, according to a study by researchers at Yale School of Medicine and Washington University's School of Medicine.
Yale procedure cuts recurrence of aggressive uterine cancer
Medical Implants : 22 September, 2005
A state-of-the-art treatment program developed at Yale School of Medicine increases survival from the aggressive uterine papillary serous carcinoma and spares some patients the need for additional therapy.
Gene that controls the severity of asthma identified
Medical Implants : 20 September, 2005
School of Medicine researchers identified a gene prevalent in the population that controls the clinical severity of asthma, according to their report in this week's Proceedings of the National Academy of Sciences.
Promising diagnostic tools for multiple sclerosis
Medical Implants : 20 September, 2005
Yale School of Medicine researchers, in collaboration with the University of Connecticut Health Center, have identified three rapid diagnostic methods that can target antibodies commonly found in multiple sclerosis patients, greatly improving potential diagnosis and treatment.
Aortic aneurysm associated with decreased incidence of atherosclerosis
Medical Implants : 19 September, 2005
Oddly enough, having an aneurysm in the ascending aorta is significantly associated with decreased incidence of atherosclerosis, according to a study by Yale School of Medicine researchers published this month in Chest.
Eating and body weight regulated by specific neurons
Medical Implants : 12 September, 2005
Researchers at Yale School of Medicine provide direct evidence that two parts of a neuronal system, one that promotes eating and another that suppresses eating, are critical for the acute regulation of eating and body weight, according to a study published online in the September 11 issue of Nature Neuroscience.
Most embryos produced during IVF do not result in live births
Medical Implants : 08 September, 2005
Researchers at Yale School of Medicine have found that 85 percent of embryos transferred during in vitro fertilization fail to become live births, highlighting the need for improving diagnostic techniques to identify viable embryos.
Inconsistent effort may be sign of attention disorder in adults and children
Medical Implants : 08 September, 2005
The adult or child who only concentrates when performing an activity in which they have a deep interest, such as playing a sport or drawing, may have 'impotence of the mind,' according to a new book by Thomas E. Brown, clinical professor of psychiatry at Yale School of Medicine.
Common pesticide may reduce fertility in women
Medical Implants : 06 September, 2005
Methoxychlor, a common insect pesticide used on food crops, may interfere with proper development and function of the reproductive tract, leading to reduced fertility in women, researchers at Yale School of Medicine write in the August issue of Endocrinology.
GABA halts stem cell production in the brain
Medical Implants : 01 September, 2005
Release of the neurotransmitter GABA by adult neuronal precursor cells that develop into neurons limits stem cell proliferation, according to a study at Yale School of Medicine in the September issue of Nature Neuroscience.
Studies Find Possible Drug Targets for Improving Vascular Health
Medical Implants : 25 August, 2005
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences.
Brain distinguishes between nose and mouth odors
Medical Implants : 19 August, 2005
Researchers in a study in Neuron this week present the first clear evidence that the brain processes the same odorant molecule differently if it arrives through the nose rather than the mouth.
Race and sex disparities in heart attack care, survival not improving
Medical Implants : 17 August, 2005
Differences based on race and sex in treatment patterns for hospitalized American heart attack patients have remained unchanged over an eight-year period, despite improvements in quality of heart attack care during this time, Emory and Yale School of Medicine researchers write in the August 18 issue of New England Journal of Medicine.
Few changes in antipsychotic prescription seen after diagnosis of diabetes
Medical Implants : 09 August, 2005
Among patients being treated with antipsychotic medication, including those who were taking the most generation of drugs, a new diagnoses of diabetes did not result in substantial changes in prescription, according to a a study at Yale School of Medicine.
Medication eases obsessive-compulsive symptoms
Medical Implants : 29 July, 2005
A medication used to ease symptoms of amyotrophic lateral sclerosis, or Lou Gehrig's disease, also is helpful in treating people with treatment-resistant obsessive-compulsive disorder, according to a pilot study at Yale School of Medicine.
Decreased breast cancer survival associated with high TRAIL-R2 expression
Medical Implants : 25 July, 2005
High expression of TRAIL-R2, a cell surface receptor that triggers cell death, has been shown to be associated with a decrease in the survival rates of breast cancer patients according to a study published by Yale Cancer Center researchers in Clinical Cancer Research.
Clinical trial tests cholesterol drug to minimize multiple sclerosis
Medical Implants : 21 July, 2005
Yale School of Medicine is participating in the first clinical trial testing atorvastatin to delay or decrease disease in patients who have experienced a first attack of multiple sclerosis.
Early estrogen therapy to prevent heart disease focus of Yale study
Medical Implants : 21 July, 2005
Researchers at Yale School of Medicine and seven other national institutions are recruiting patients to participate in the Kronos Early Estrogen Prevention Study to look at the effects of estrogen on heart disease prevention.
Understanding and diagnosing an inherited pain syndrome
Medical Implants : 12 July, 2005
Yale School of Medicine researchers report the first demonstration that a single mutation in a human sodium channel gene can trigger pain in people with an inherited pain syndrome known as primary erythromelalgia, according to a study published this month in the journal Brain.
Protein amplification in melanoma is possible drug target
Medical Implants : 11 July, 2005
Researchers have pinpointed specific gene and protein over-production in metastatic melanoma, pointing the way to a possible new drug target, according to a study published in Nature July 7.
Groundbreaking study helps explain why preemie brains improve over time
Medical Implants : 27 June, 2005
Infants born prematurely and with hypoxia, inadequate oxygen to the blood, are able to recover some cells, volume and weight in the brain after oxygen supply is restored, Yale School of Medicine researchers report in Experimental Neurology.
Nicotine helps Schizophrenics with attention and memory
Medical Implants : 23 June, 2005
Cigarette smoking may improve attention and short
Breast cancer growth regulator holds promise for more targeted treatment
Medical Implants : 22 June, 2005
Researchers at Yale School of Medicine have discovered the breast cancer growth regulator sEGFR, which may be a useful tool in monitoring a patient's responsiveness to treatment with the drug letrozole.
Yale scientists find MicroRNA regulates ras cancer gene
Medical Implants : 17 March, 2005
Research in the laboratory of Assistant Professor Frank J. Slack at Yale University has identified a new way that a familiar gene is regulated in lung cancer, presenting new possibilities for diagnosis and treatment. The work is reported in March issues of the journals Cell and Developmental Cell.
Boosting HIV screening can increase survival and is cost effective
Medical Implants : 09 February, 2005
Expanded HIV screening can increase patient life span, prevent the spread of the disease, and is cost effective, researchers at Yale, Harvard and the Massachusetts General Hospital report in the February 10 issue of the New England Journal of Medicine.
Varicella vaccine effective on chicken pox
Medical Implants : 03 February, 2005
The varicella vaccine is almost 90 percent effective against chickenpox, but its impact on herpes zoster (shingles) is unknown and needs wider surveillance, Yale School of Medicine researchers write in today's New England Journal of Medicine perspective section.
Premature births from inflammation and infection rapidly detected by proteomics technology
Medical Implants : 26 January, 2005
A combination of four proteins that result from inflammation and infection and lead to premature birth can be rapidly and accurately detected in the amniotic fluid of pregnant women using proteomics technology, Yale researchers report in two studies in the February issue of British Journal of Obstetrics and Gynecology
Blocking molecule protects health of implants
Medical Implants : 20 December, 2004
Blocking a key molecule protects breast implants, permanent catheters, pacemakers, artificial joints, glucose sensors for diabetics, and other biomaterials from rejection and damage by the body, according to a study published this month in The American Journal of Pathology.
World's first medical grade 17' terminal for graphics-intensive applications
Medical Implants : 09 April, 2004
Aimed at the market for graphics-intensive medical applications, POC-174 is based on the Mobile Intel Pentium 4 Processor-M, and is UL60601-1, EN60601 certified. POC-174's TFT LCD screen has a wide viewing angle of 170 degrees, which combined with high contrast ratio, high brightness and resolution, makes it the Point-of-care terminal of choice for applicationssuch as CT diagnosis, X-rays, PACS and DICOM.
Brain area that regulates emotions is smaller in persons with bipolar disorder
Medical Implants : 18 December, 2003
A brain scanning study of adolescents and adults with bipolar disorder shows significant decrease in size in the amygdala, a brain structure that governs emotions, a Yale School of Medicine researcher has found.
Clinical trial for patients with lung cancer and brain metastases
Medical Implants : 09 December, 2003
A clinical trial testing a new medication and whole brain radiation therapy for patients with non-small cell lung cancer and brain metastases is underway at Yale School of Medicine.
Studies question economics of anti-psychotic and anti-depressant drugs
Medical Implants : 02 December, 2003
Two Yale studies question the economics of medications in the two most widely prescribed and costly classes of psychiatric medications. One study found that a new and more expensive anti-psychotic drug is not more effective than a less costly, older one, and the second study found that industry-associated economic studies of antidepressants favor the companies' new drugs when determining costs and cost-effectiveness.
First | Prev  | 1 | 2 | 3 | 4  | Next  | Last
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo